Last reviewed · How we verify
Albuterol and budesonide inhalation aerosol — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Albuterol and budesonide inhalation aerosol (Albuterol and budesonide inhalation aerosol) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Albuterol and budesonide inhalation aerosol TARGET | Albuterol and budesonide inhalation aerosol | AstraZeneca | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Albuterol and budesonide inhalation aerosol CI watch — RSS
- Albuterol and budesonide inhalation aerosol CI watch — Atom
- Albuterol and budesonide inhalation aerosol CI watch — JSON
- Albuterol and budesonide inhalation aerosol alone — RSS
Cite this brief
Drug Landscape (2026). Albuterol and budesonide inhalation aerosol — Competitive Intelligence Brief. https://druglandscape.com/ci/albuterol-and-budesonide-inhalation-aerosol. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab